CNTBHIGH SIGNALFINANCIAL10-K

CNTB experienced a dramatic revenue collapse with virtually no sales recorded in the current period while burning substantial cash and increasing liabilities.

The near-complete disappearance of revenue alongside continued high R&D spending suggests the company may be facing severe operational challenges or has undergone a fundamental business transformation. The substantial cash burn combined with increased liabilities and reduced stockholder equity raises questions about the company's financial sustainability and ability to fund ongoing operations.

Comparing 2026-03-31 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

CNTB's financial position deteriorated markedly, with revenue essentially evaporating while R&D expenses grew notably to $37.8M. The company's balance sheet weakened significantly as cash reserves declined to $38.3M from $78.2M, current liabilities increased 60.9%, and stockholders' equity fell by more than half to $42.0M. This combination of minimal revenue generation, continued high expenses, and substantial asset reduction signals a company in potential financial distress.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
-99.8%
$26.0M→$64K

Revenue declined 99.8% — significant demand weakness or market share loss warrants investigation.

Accounts Receivable
Balance Sheet
-98.4%
$789K→$13K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Current Liabilities
Balance Sheet
+60.9%
$8.5M→$13.6M

Current liabilities surged 60.9% — significant near-term obligations; verify ability to meet short-term debt.

Total Liabilities
Balance Sheet
+54.6%
$9.1M→$14.1M

Liabilities grew 54.6% — significant increase in debt or obligations, assess impact on financial flexibility.

Stockholders Equity
Balance Sheet
-54.5%
$92.2M→$42.0M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Cash & Equivalents
Balance Sheet
-51%
$78.2M→$38.3M

Cash declined 51% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Assets
Balance Sheet
-47.5%
$97.0M→$50.9M

Current assets declined 47.5% — monitor working capital adequacy and short-term liquidity.

Total Assets
Balance Sheet
-44.6%
$101.3M→$56.1M

Total assets contracted 44.6% — asset sales, write-downs, or balance sheet optimization underway.

Capital Expenditure
Cash Flow
-42.1%
$750K→$434K

Capex reduced 42.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

R&D Expense
P&L
+29.2%
$29.3M→$37.8M

R&D investment increased 29.2% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-31
ADDED
As of March 26, 2026, there were 56,521,282 ordinary shares of the Company ($0.000174 par value) outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 105 Item 7A.
Although the Company has voluntarily elected to file annual, periodic and current reports on U.S.
federal proxy rules pursuant to Section 14 of the Exchange Act and Regulations 14A and 14C thereunder, and Regulation FD.
On December 18, 2025, as part of the National Defense Authorization Act for Fiscal Year 2026, the Holding Foreign Insiders Accountable Act (the HFIAA ) was signed into law.
The Company s officers, directors, and principal shareholders are not subject to the short-swing profit recovery provisions contained in Section 16.
These statements are often identified by the use of words such as aim, anticipate, assume, believe, contemplate, continue, could, design, due, estimate, expect, goal, intend, may, might , objective, plan, positioned, potential, predict, seek, should, target, will, would and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology.
We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, operating results, business strategy, short-term and long-term business operations and objectives.
Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
Our estimates of the potential market opportunities for our product candidates include several key assumptions based on our industry knowledge, industry publications, third-party research, and other surveys, which may be based on a small sample size and may fail to accurately reflect market opportunities.
REMOVED
As of March 21, 2025, there were 55,349,208 ordinary shares of the Company ($0.000174 par value) outstanding.
Management s Discussion and Analy sis of Financial Condition and Results of Operations 102 Item 7A.
Although the Company has voluntarily elected to file annual reports, periodic reports and current reports on U.S.
federal proxy rules pursuant to Section 14 of the Exchange Act and Regulations 14A and 14C thereunder, Regulation FD, and its officers, directors, and principal shareholders are not subject to the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In some cases, you can identify forward-looking statements by terminology such as aim, anticipate, assume, believe, contemplate, continue, could, design, due, estimate, expect, goal, intend, may, might , objective, plan, positioned, potential, predict, seek, should, target, will, would and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology.
We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.
These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions described in the sections titled Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report.
Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
This report includes statistical and other industry and market data that we obtained from industry publications and research, surveys, and studies conducted by third parties as well as our own estimates of potential market opportunities.
The regulatory approval processes of the United States ( U.S.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →